Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...
US FDA says lowest dose of Novo Nordisk's weight-loss drug now available
The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available, the U.S. health regulator's website ...
Ozempic and Wegovy considered ‘available’ after more than two years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...
Novo takes big step toward ending Ozempic, Wegovy shortages
All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned ...
Ozempic, Wegovy move closer to no longer being in shortage, FDA says
After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as ...
STAT12h
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...
Hims & Hers stock falls 14% after FDA changes semaglutide supply status (update)
Hims & Hers (HIMS) stock fell 14% following news that Novo Nordisk’s (NVO) weight-loss drug Wegovy is no longer ...
Tiziana Life Sciences announces results from ozempic, nasal anti-CD3 study
Tiziana Life Sciences (TLSA) announced positive results demonstrating the anti-inflammatory potential of our anti-CD3 antibody in combination ...
Did Karan Johar use Ozempic? The controversial rise of a diabetes drug for weight loss
Karan Johar’s recent weight loss has sparked rumors linking him to Ozempic, a diabetes drug now popular for its weight-loss ...
Eli Lilly: The Stock Might Have Peaked
Eli Lilly and Company disappointed with missed earnings, lower guidance. Click here for my review of LLY Q3 earnings and a ...
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
Hims & Hers Health shares are falling Thursday following an FDA update listing Novo Nordisk diabetes drug Ozempic and weight-loss drug Wegovy as available, signaling possible supply stability. Here's ...